The pitch: V3 promises faster treatments, finer dosing, and smarter delivery through refined needles, micro‑pump control, or AI‑guided placement. That can mean better outcomes — smoother contours, less bruising, more predictable results — but it also concentrates risk in a device that makes injections easier and more accessible. The core question: does greater ease justify broader use outside trained hands?